Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sep 2017 5:18 AM GMTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...